8CYH
Novel Anti-Mesothelin Antibodies Enable Crystallography of the Intact Mesothelin Ectodo- main and Engineering of Potent, T cell-engaging Bispecific Therapeutics
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | ALS BEAMLINE 5.0.2 |
Synchrotron site | ALS |
Beamline | 5.0.2 |
Temperature [K] | 100 |
Detector technology | PIXEL |
Collection date | 2019-08-29 |
Detector | DECTRIS PILATUS 6M |
Wavelength(s) | 0.97926 |
Spacegroup name | I 2 2 2 |
Unit cell lengths | 65.112, 124.862, 302.748 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 44.380 - 3.380 |
R-factor | 0.2315 |
Rwork | 0.230 |
R-free | 0.26760 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 4f3f |
RMSD bond length | 0.006 |
RMSD bond angle | 1.140 |
Data reduction software | HKL-2000 |
Data scaling software | SCALEPACK |
Phasing software | PHASER |
Refinement software | REFMAC (5.8.0267) |
Data quality characteristics
Overall | Inner shell | Outer shell | |
Low resolution limit [Å] | 50.000 | 50.000 | 3.410 |
High resolution limit [Å] | 3.350 | 9.080 | 3.350 |
Rmerge | 0.149 | 0.049 | 0.934 |
Rmeas | 0.164 | 0.055 | 1.035 |
Rpim | 0.068 | 0.025 | 0.438 |
Total number of observations | 101701 | ||
Number of reflections | 17506 | 953 | 842 |
<I/σ(I)> | 8.4 | ||
Completeness [%] | 98.7 | 96.9 | 96.1 |
Redundancy | 5.8 | 4.7 | 5.6 |
CC(1/2) | 0.996 | 0.598 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, HANGING DROP | 8 | 295 | Tris (8.0), sodium citrate, Peg3350 |